Real World Treatment Experience of Patients With Breast, Lung, Ovarian, Multiple Myeloma, or Acute Myelogenous Leukemia Using Remote Symptom Monitoring

Part of paid clinical trials in New Haven, Connecticut.

Sponsor
Carevive Systems, Inc.
Study ID
NCT05974150
Status
Recruiting

Conditions

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Web based survey — OTHER
    online weekly survey

Study Details

The goal of this study is to create a data set to add to Carevive's registry from real world clinical and patient reported data collected using an electronic care planning system (CPS) with remote symptom monitoring that is used in routine care for cancer patients on active treatment. Patients will complete a baseline survey in person using a secured device or remotely using their own electronic device in a location of their choice. Weekly electronic patient reported outcome (PRO) surveys are collected from the patients using the Carevive platform for a minimum of 12 weeks. Patients may continue weekly surveys as long as they are receiving treatment.

Key Dates

Start date
Jul 19, 2023
Status verified
Feb 2026
Primary completion
Nov 5, 2026
Completion
Dec 31, 2026

Study Design

Enrollment
25 participants (estimated)

Primary Outcome Measure

Create Data Set [ Time Frame: 1 year ]

Central Contacts

Locations (7)

FacilityCityStateZIPSite coordinators
Yale Cancer CenterNew HavenConnecticut06511-
Northshore University Health SystemEvanstonIllinois31024
Michele Britto
Nicklas Pfanzelter (PRINCIPAL_INVESTIGATOR)
Univeristy of North Carolina at Chapel HillChapel HillNorth Carolina27599-
DukeDurhamNorth Carolina27707-
Cleveland Clinic Mercy HospitalCantonOhio44708
Janet Muckley
Mitchell Haut, MD (PRINCIPAL_INVESTIGATOR)
University Hospitals Seidman Cancer CenterClevelandOhio44106
Jill Severino-Powell, MSN
Alberto Montero, MD (PRINCIPAL_INVESTIGATOR)
Tri-County Hematology & Oncology Associates, Inc.MassillonOhio44646
Janet Muckley
Nagaprasad Nagajothi, MD (PRINCIPAL_INVESTIGATOR)

Find similar trials in New Haven, CT

Related Studies